Entry |
|
Name |
Etripamil (USAN/INN) |
Formula |
C27H36N2O4
|
Exact mass |
452.2675
|
Mol weight |
452.58
|
Structure |

|
Simcomp |
|
Remark |
|
Efficacy |
Antiarrhythmic, Calcium channel blocker |
Comment |
Phenylalkylamine derivative
Treatment of paroxysmal supraventricular tachycardia (PSVT)
|
Target |
|
Pathway |
hsa04270 | Vascular smooth muscle contraction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C08 CALCIUM CHANNEL BLOCKERS
C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
C08DA Phenylalkylamine derivatives
C08DA03 Etripamil
D10932 Etripamil (USAN/INN)
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA1-L
D10932 Etripamil (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 33
1 C1d C 15.0092 -14.7934
2 C8y C 13.7474 -15.4944
3 C1b C 16.2009 -15.4944
4 C1c C 15.0092 -13.3914
5 C8x C 12.5557 -14.7934
6 C8x C 13.7474 -16.8964
7 C1b C 17.3925 -14.7934
8 C1a C 16.2710 -12.6904
9 C1a C 13.8175 -12.6904
10 C8y C 11.3640 -15.4944
11 C8x C 12.5557 -17.5974
12 C1b C 18.5842 -15.4944
13 C8y C 11.3640 -16.8964
14 O2a O 10.1022 -14.7934
15 N1c N 19.8460 -14.7934
16 O2a O 10.1022 -17.5974
17 C1a C 8.9105 -15.4944
18 C1b C 21.0377 -15.4944
19 C1a C 19.8460 -13.3914
20 C1a C 8.9105 -16.8964
21 C1b C 22.2995 -14.7934
22 C8y C 23.4912 -15.4243
23 C8x C 24.6829 -14.7233
24 C8x C 23.4912 -16.8263
25 C8y C 25.8745 -15.4243
26 C8x C 24.6829 -17.5273
27 C8x C 25.8745 -16.8263
28 C7a C 27.1363 -14.7233
29 O7a O 28.3280 -15.4243
30 C3b C 16.2216 -14.0934
31 N3a N 17.4340 -13.3934
32 O6a O 27.1535 -13.3000
33 C1a C 29.5732 -14.7191
BOND 34
1 1 2 1
2 1 3 1
3 1 4 1 #Up
4 2 5 2
5 2 6 1
6 3 7 1
7 4 8 1
8 4 9 1
9 5 10 1
10 6 11 2
11 7 12 1
12 10 13 2
13 10 14 1
14 12 15 1
15 13 16 1
16 14 17 1
17 15 18 1
18 15 19 1
19 16 20 1
20 18 21 1
21 21 22 1
22 22 23 1
23 22 24 2
24 23 25 2
25 24 26 1
26 25 27 1
27 25 28 1
28 28 29 1
29 11 13 1
30 26 27 2
31 1 30 1 #Down
32 30 31 3
33 28 32 2
34 29 33 1
|